Should You Buy Precision BioSciences Inc (DTIL) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
DTIL is not a good buy right now for a beginner, long-term investor with $50k–$100k who is impatient and doesn’t want to wait for a better entry. The stock is trending weak (recent -4.12% regular session, -2.18% pre-market), fundamentals show a severe revenue collapse in 2025/Q3, and insider selling has surged. With no supportive proprietary buy signals today and no fresh positive news catalysts, the risk/reward is unfavorable for a long-term “buy now” decision.
Technical Analysis
Price/Trend: DTIL is trading around ~3.94–3.96 post-market, below the pivot (4.156), indicating a slightly bearish/under-pressure setup.
Momentum: MACD histogram is above 0 (0.0384) but positively contracting, suggesting fading upside momentum rather than strengthening trend.
RSI: RSI(6)=40.12 (neutral-to-weak), not oversold enough to imply a high-conviction bounce.
Moving Averages: Converging MAs suggests consolidation; with price below pivot, consolidation is not yet resolving bullishly.
Levels: Support S1=3.837 (near current price) then S2=3.639; Resistance R1=4.475 then R2=4.673. Given current weakness, the most immediate technical risk is a breakdown through 3.84.
Pattern-based short-term odds: Similar-pattern model implies slightly negative 1-month bias (-1.15%), not supportive for an impatient buyer.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.